Principal Securities »

Design Therapeutics shares owned by Principal Securities

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Principal Securities from 13F filings

Historical chart of Principal Securities investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Principal Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Principal Securities

Quarter filed Position value Share count Share price at filing
2024-09-30 $398 74 5.38
2024-06-30 $248 74 3.35

More positions owned by Principal Securities

Principal Exchange Traded Us Mega Cp Etf (USMC)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Goldman Sachs Etf Tr Marketbeta Us Eq (GSUS)
Principal Exchange Traded Prin U S Small (PSC)
Microsoft Corporation (MSFT)
Principal Exchange Traded Focused Blue Chi (BCHP)
Ishares Tr Rus 1000 Etf (IWB)
Amazon (AMZN)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Apple (AAPL)
Principal Exchange Traded Prnc Invt Grad (IG)
Principal Exchange Traded Prncpl Vlu Etf (PY)
Goldman Sachs Etf Tr Activebeta Int (GSIE)

View all positions for Principal Securities

Top funds holding Design Therapeutics

Sr One Capital Management
Logos Global Management
BlackRock
BlackRock
Frazier Life Sciences Management
Baker Bros. Advisors
Point72 Asset Management
Tang Capital Management
Almitas Capital
Vanguard Group
Geode Capital Management
State Street Corporation
Goldman Sachs Group
Acadian Asset Management
D. E. Shaw & Co

View all funds holding Design Therapeutics